Gary Li
Impact in
- Pharmaceutical Science top 5%
- Advancements in Transdermal Drug Delivery
- Virology top 10%
Papers in
-
- Fibroblast Growth Factor Research 7
-
- Radiopharmaceutical Chemistry and Applications 7
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Sameek Roychowdhury (4 shared papers)Melanie A. Krook (3 shared papers)Hui‐Zi Chen (1 shared paper)Gabrielle Ernst (1 shared paper)Julie W. Reeser (1 shared paper)Max Wilberding (1 shared paper)Kenneth H. Grabstein (4 shared papers)Kurt Shanebeck (3 shared papers)
- Journals
- Cancer Research (9 papers)Journal of Clinical Oncology (6 papers)Oncotarget (2 papers)Bioconjugate Chemistry (2 papers)Molecular Cancer Therapeutics (1 paper)
- Partner nations
- United StatesItalyBelgium
In The Last Decade
Gary Li
31 papers receiving 880 citations
Gary Li's Hit Papers
Peers
Comparison fields: 5 of 87
- Pharmaceutical Science 86
- Virology 41
- Immunology 170
- Oncology 192
- Radiology, Nuclear Medicine and Imaging 137
Countries citing papers authored by Gary Li
This map shows the geographic impact of Gary Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Li more than expected).
Fields of papers citing papers by Gary Li
This network shows the impact of papers produced by Gary Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Li. The network helps show where Gary Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Gary Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Fibroblast growth factor receptors in cancer: genetic alterations, diagnostics, therapeutic targets and mechanisms of resistance Hit paper breakdown → | 2020 | 231 |
| 2 | A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines Hit paper breakdown → | 2023 | 132 |
| 3 | 2015 | 123 | |
| 4 | 2019 | 71 | |
| 5 | 2011 | 51 | |
| 6 | 2020 | 42 | |
| 7 | 2015 | 41 | |
| 8 | 2024 | 33 | |
| 9 | 2018 | 29 | |
| 10 | 2023 | 28 | |
| 11 | 2017 | 20 | |
| 12 | 2014 | 18 | |
| 13 | 2015 | 15 | |
| 14 | 2023 | 14 | |
| 15 | 2015 | 9 | |
| 16 | 2019 | 7 | |
| 17 | 2024 | 6 | |
| 18 | 2020 | 5 | |
| 19 | 2020 | 3 | |
| 20 | 2019 | 3 |
About Gary Li
Gary Li is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 901 indexed citations. Recurring topics across this work include Fibroblast Growth Factor Research (7 papers), Radiopharmaceutical Chemistry and Applications (7 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Lung Cancer Research Studies (5 papers), Lung Cancer Treatments and Mutations (5 papers), Cancer, Hypoxia, and Metabolism (5 papers), Phagocytosis and Immune Regulation (4 papers) and Cancer Genomics and Diagnostics (3 papers). The work is most often cited by research in Pharmaceutical Science (86 citations), Virology (41 citations), Immunology (170 citations), Oncology (192 citations) and Radiology, Nuclear Medicine and Imaging (137 citations). Gary Li has collaborated with scholars based in United States, Italy and Belgium. Frequent co-authors include Sameek Roychowdhury, Melanie A. Krook, Hui‐Zi Chen, Gabrielle Ernst, Julie W. Reeser, Max Wilberding, Kenneth H. Grabstein, Kurt Shanebeck, Jeffrey Johnson and Pauline A. Bariola. Their work appears in journals such as Cancer Research, Journal of Clinical Oncology, Oncotarget, Bioconjugate Chemistry and Molecular Cancer Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.